PharmiWeb.com - Global Pharma News & Resources

Conference - Events

Featured Events

Events

18-Mar-2025 - 19-Mar-2025
Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. The 2025 agenda is streamed by priority - spotlighting use cases and tangible learnings across the key topic areas of customer engagement, tools and technology, value demonstration, and future proofing strategies. Outside of the conference rooms, attendees form connections through our hyper-interactive hackathons, workshops, roundtables, meet-and-eats, and our networking drinks reception. Don't hear about it after - be in the room. Time: 9:00 AM - 4:00 PM
Reuters Events: Pharma USA 2025
We are thrilled to extend a warm welcome to the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), scheduled to take place from 19-22 March, 2025, in Amsterdam, The Netherlands. We invite you to join us at ATTD, the premier international platform, where clinicians, diabetes care providers, researchers, industries, startups, investors, reimbursement authorities, regulators, and individuals living with diabetes convene with the shared aim of enhancing diabetes care at an accelerated pace. The conference will feature presentations and discussions led by esteemed professionals in the field, covering a diverse range of topics including artificial intelligence-driven decision support systems, glucose sensors, closed-loop systems, artificial pancreas t…
ATTD 2025 - 18th International Conference on Advanced Technologies and Treatments for Diabetes
25-Mar-2025 - 27-Mar-2025
Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and Parvus and AbbVie, creating a surge of innovation and spotlighting Treg cell therapies and modulators as the next frontier in autoimmune and inflammatory disease treatments. Tregs hold the potential to revolutionize care for conditions that have long lacked effective solutions and are the future of precision medicine in autoimmune and inflammatory diseases.   Date and Time: Tuesday, 25 March 2025 at 08:00 to Thursday, 27 March 2025 at 17:00
7th Treg-Directed Therapies Summit
Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy approvals in the last 18 months, billion-dollar collaborations, and the development of treatments for more common conditions, the gene therapy field is rapidly gaining momentum and broadening scope beyond rare diseases. Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders Summit, will unite 200+ gene therapy experts to tackle the field's biggest challenges of achieving genuine scalability and accessibility to meet growing patient demand. For the first time, this industry-defining meeting will reflect the field's growing focus on developing therapies for common diseases, whil…
8th Gene Therapy Development Summit 2025
Selecting the right CMO/CDMO is no longer merely about capabilities; it's about establishing resilient relationships that can withstand disruption. Effective partnerships require a nuanced approach that balances efficiency, flexibility, and alignment on quality standards. The conference is dedicated exclusively to enhancing CMO selection and partnerships. It brings together industry leaders, experts, and innovators from the CMO/CDMO and pharmaceutical industries to engage in meaningful discussions and share best practices. Find out more here: https://shorturl.at/UTil3🖊️ The topics covered in our sessions will surround the challenges of today: -Challenges surrounding global uncertainties -Sustainability pressures -Evolving regulations -Pricing negotiations -The push for digital transformat…
Pharma Contract Manufacturing 2025 (26-27th March)
EDUCATION IS OUR TOP PRIORITY! With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. ABOUT US The Association of Vascular and Interventional Radiographers (AVIR) is a nonprofit, national organization of Radiologic Technologists and allied health professional deeply committed to improving health and the quality of life through the practice of vascular and interventiona…
(AVIR) Association of Vascular and Interventional Radiographers Annual Meeting, Mar 30-Apr 1, 2025
01-Apr-2025 - 03-Apr-2025
2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T, CDR-Life, and TScan, along with a wealth of investment and partnerships amounting to over $700M, it's time to come together to relish in these breakthroughs, while pouring this energy into expanding TCR treatment potential. The 6th TCR-Based Therapies Summit returns as the only TCR-specific platform for industry experts to join forces to share the technical insights to transform discovery, translation, R and D, and clinical development for cell- and biologic-based approaches. Providing an unmatched close-knit collaboration environment created specifically with and for the TCR community to connect, and learn from lead…
6th TCR-Based Therapies Summit
01-Apr-2025 - 03-Apr-2025
With Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide continuing its phase 3 journey, and Chugai advancing peptides into the intracellular space, peptide therapeutics are firmly back on the map as the next modality disrupting drug discovery and development. This includes exploring peptide structure prediction using AI/ML technologies, designing orally bioavailable and cell membrane-permeable peptides using structure-based molecular design, harnessing mRNA display and DNA-encoded libraries for peptide discovery, optimizing peptide synthesis, integrating formulation considerations at the discovery stage, and investigating peptides as drug delivery vehicles. The 2nd Peptide-Based Therapeutics Summit returns to Boston as your most comp…
2nd Peptide-Based Therapeutics Summit
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery or emergency use, nasal delivery is opening a new era of more efficient drug and vaccine administration with life-saving potential. However, challenges in biologics formulation, along with renewed interest from major pharmaceutical companies and investors, raise questions about how other companies are addressing development obstacles and the most effective strategies to secure funding. Dedicated to navigating investment pathways for nasal companies, boosting drug bioavailability in target regions, optimizing translational modelling, and determining the efficacy of delivery devices, the 3rd Nasal Formulation and De…
3rd Nasal Formulation and Delivery Summit
Unlock the full potential of your alliances at the 16th Strategic Alliance Management conference for Pharma, where industry leaders and innovators come together to redefine the art of partnership. This year’s agenda dives deep into the lifecycle of alliances—from negotiation and deal structuring to performance monitoring and seamless termination. Explore cutting-edge tools and methodologies to measure alliance value, resolve conflicts, and optimize outcomes. Gain insights into bridging the gap between partners, tackling internal organizational challenges, and aligning strategies to expand existing deals. With a special emphasis on big-pharma and biotech perspectives, this event offers a unique platform for forward-thinking collaboration.    Attending This Premier marcus evans Eve…
16th Strategic Alliance Management conference for Pharma
With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this delivery vehicle is truly exciting! The 4th LNP Formulation and Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver. With a revamped track design, the 2025 meeting has 3 dedicated streams, Analytical Development and Characterization, Formulation and Delivery and Process Development and Manufac…
4th Annual LNP Formulation and Process Development Summit
24-Apr-2025 - 25-Apr-2025
The Research Gate (TRG) creates an international platform for exchanging ideas and best practices in a manner that demonstrates respect for diversity and inclusion.  TRG invites participants from the global healthcare community to attend the International Conference on Neuropsychiatry & Mental Health 2025 on April 24-25, 2025.  This conference will feature Neurologists, Neurosurgeons, Psychiatrists, Psychologists, Neurobiologists, Neuroimmunology’s and Members from Neurology Organizations.  The Neuropsychiatry & Mental Health 2025 strives to promote evidence-based strategies, increased collaboration among healthcare professionals, and increased quality of care to address the challenges of a rapidly changing healthcare environment. 
Neuropsychiatry & Mental Health 2025
The 4th ADC Analytical Development Summit is returning to Boston in April 2025. This event will bring together the brightest minds in the field to address the unique analytical challenges of antibody-drug conjugates. As regulatory expectations tighten and ADCs become increasingly complex, this summit will serve as your guide to ensuring high-quality products and seamless regulatory submissions. With the FDA’s updated ICH Q14 guidance raising the bar for release and stability testing, adopting advanced analytical methods is more critical than ever to maintain product quality. This summit offers a unique platform to explore how to meet these regulatory requirements effectively while ensuring your ADC remains robust throughout its lifecycle. ADC developers are increasingly working with novel…
4th Annual ADC Analytical Development Summit
It is no secret that GLP-1 receptor agonists have transformed the treatment of obesity and diabetes. The past 12 months have seen the GLP-1 landscape transform into something truly unrecognizable in previous years, with the global GLP-1 analogues market valued at US$47.4 billion in 2024. With the next frontier of these blockbuster therapeutics well on its way to approval, the GLP-1 field is only going to grow, with novel combinations, indications, and formulations being explored. From MASH to Parkinson's disease, there is potential for GLP-1s to become a ‘magic bullet' across healthcare, only adding to the ever-increasing market value. In this highly competitive market, Novo Nordisk and Eli Lilly currently lead with first-in-class GLP-1 therapies. However, the race is now focused on develo…
2nd GLP-1-Based Therapeutics Summit 2025
With the mRNA market projected to reach $63.28 billion by 2025, the global demand for mRNA vaccines and therapeutics is at an all-time high. Now more than ever, robust process development and manufacturing are essential to ensure patients have access to life-saving treatments. While the industry is making strides in continuous processing, advanced analytics, improved scalability, and innovative formulations, significant challenges remain, including controlling impurities, long manufacturing timelines, and navigating complex regulatory pathways for timely approvals. The 3rd mRNA Process Development and Manufacturing Summit 2025 returns as Europe's premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines. This event will address end-to-en…
3rd mRNA Process Development and Manufacturing Summit Europe 2025